期刊文献+

荧光淬灭法分析奈韦拉平含量 被引量:2

Determination of Nevirapine by Fluorescence Quenching
下载PDF
导出
摘要 目的 建立测定奈韦拉平含量的新方法.方法 采用合成的荧光试剂[Ni(phen)2 PHPIP]·2ClO4],在激发波长226 nm,发射波长340 nm的条件下,用荧光淬灭法测定奈韦拉平.结果 在pH 6.0的磷酸盐缓冲介质中,荧光试剂的荧光淬灭程度与奈韦拉平浓度呈良好的线性关系.奈韦拉平的线性范围为5.0×10^-7~1.0×10^-5mol/L,检测限为1.0×10^-7mol/L,相关系数0.9946,奈韦拉平回收率102%(n=5),RSD 2.57%,日内及日间RSD分别为2.64%和3.77%(n=5).结论 测定奈韦拉平含量的荧光淬灭方法具有杂质干扰少、操作简便等优点. Objective To perform a fluorescence quenching method for determine the concentration of nevirapine. Methods A fluorescence quenching method has been developed for the determination of nevirapine. The excitative wavelength was 226 nm and emission wavelength was 340 nm. Results The calibration curve was linear over the range of (5.0×10^-7~1.0×10^-5mol/L) mol/L. Correlation coefficient was 0. 9946. The recovery rate of nevirapine was 102% (n= 5) and the relative standard deviation (RSD) was 2.57%. The RSD for intra-day and inter-day were 2.64%(n=5) and 3.77%(n=5) respectively. Conclusion Fluorescence quenching method is an accurate method for determination of nevirapine level.
出处 《福建医科大学学报》 2006年第5期523-525,共3页 Journal of Fujian Medical University
关键词 荧光淬灭 奈韦拉平 fluorophotometry fluorescent probes nevirapine
  • 相关文献

参考文献5

二级参考文献33

  • 1吴建中,王雷,杨光,曾添贤,计亮年.钌多吡啶配合物的合成及结合DNA的研究[J].高等学校化学学报,1996,17(7):1010-1015. 被引量:41
  • 2徐莲芝编著.实用艾滋病防治指南M[M].天津:天津科学技术出版社,2000.346~368.
  • 3[1]Hargrave KD, Proudfoot JR, Adams J, et al . 5.11-Dihydro-6H-dipyrido (3,2-B:2',3'-E)(1,4) diazepines and their use in the prevention or treatment of HIV infection[S]. US.Cl 514/220,5366972.1994.12
  • 4[2]Temesgen Z, Wright AJ. Antiretrovirals[J]. Mayo Clin Proc, 1999;74:1284-301
  • 5[3]Voelker R. New HIV drugs cast in supporting roles[J]. JAMA ,1996; 276:585-6
  • 6[4]Guay LA, Musoke P, Fleming T , et al. Intrapartum and neonatal single-dose nevirapine compared with zidovndine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial[J]. Lancet, 1999;354:795-802
  • 7[5]Marseille E, Kohn JG, Mmiro F, et al. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa[J].Lancet,1999;354:803-9
  • 8[6]Schneider H, Christmann A. Process for preparing nevirapine[S]. US.Cl.540/495. 5569760.1996.10
  • 9[7]Kohlstaedt LA, Wang J, Friedman JM, et al. Crystal structure at 3.5? resolution of HIV-1 reverse transicriptase complexed with an inhibitor[J]. Science,1992;256:1783-90
  • 10[8]Wu JC, Warren TC, Adams J, et al. A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site [J]. Biochemistry, 1991;30:2022-6

共引文献43

同被引文献17

  • 1周细根,陈汇.HPLC法测定奈韦拉平的血药浓度[J].实用临床医学(江西),2006,7(9):16-17. 被引量:1
  • 2YAOYa-min(姚亚敏) SUNJian-jun(孙建军).LC-MS/MS method for simultaneous quantification of nevirapine lamivudine stavudine zidovudine efavirenz in human plasma(LC-MS/MS法同时测定奈韦拉平、拉米夫定、司他夫定、齐多夫定和依非韦伦的血浆浓度)[J].公共卫生与临京医学,5(3):170-170.
  • 3Lois S.Rowland,Thomas R,Mac Gregor.Quantitation of five nevirapine oxidative metabolites in human plasma using liquid chromatography-tandem mass spectrometry.J Chromatogr B,2007,9(8):252.
  • 4Hiren NM,Pranav S,Arvind GJ,et al.Development and validation of a rapid liquid chromatography tandem mass spectrometry method to quantify nevirapine in human plasma and its application to bioequivalence study in healthy human subjects.Anal Lett,2007,40(6):1147.
  • 5Lemmer P,Schneider S,Schuman M,et al. Determination of nevirapine and efavirenz in plasma using GC/MS in selected ion monitoring mode.Ther Drug Monit,2005,(27):521.
  • 6Stefania Notari,Carmine Mancone,Tonino Alonzi.Determination of abacavir,amprenavir,didanosine,efavirenz,nevirapine,and stavudine concentration in human plasma by MALDI-TOF/TOF.J Chromatogr B,2008,863(6):249.
  • 7Elisabete A Pereira,Gustavo A Micke,Marina FM.Tavares.Determination of antiretroviral agents in human serum by capillary electrophoresis.J Chromatogr A, 2005,1091(7):169.
  • 8Palaniappan Mohanraj,Deb Kumar Sarkara and Karunakaran.Simple and rapid RP-HPLC method for the estimation of nevirapine in bulk and pharmaceutical dosage forms.E-J Chem,2008,5(S2):1081.
  • 9Prasada Rao CH,Channabasavaraj KP.Development and validation of RP-HPLC method for the estimation of nevirapine in bulk drug and tablets.J Pharm Sci Res,2009,1(2):78.
  • 10Kaul N,Agrawal H,Paradkar AR,et al.HPTLC method for determination of nevirapine in pharmaceutical dosage form.Talanta,2004,64(5):843.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部